President Trump Reclassifies Marijuana With Executive Order
Marijuana was downgraded from a Schedule I drug to a [...]
Longtime Pfizer R&D…
Longtime Pfizer R&D chief Kathy Fernando, Ph.D., has left the Big [...]
After a long and strange year,…
After a long and strange year, Belgian biotech Galapagos is [...]
Amid rapidly evolving media…
Amid rapidly evolving media consumption habits and a federal push [...]
After taking a stab at becoming a…
After taking a stab at becoming a neuroscience biotech, buzzy [...]
Daiichi Sankyo and Merck &…
Daiichi Sankyo and Merck & Co.’s phase 3 program for [...]
Eli Lilly has shown patients…
Eli Lilly has shown patients maintained most of their weight [...]
GSK is embarking on a journey with…
GSK is embarking on a journey with CAMP4 Therapeutics, paying [...]
Takeda’s closely watched and…
Takeda’s closely watched and highly valued dermatology pill zasocitinib has [...]
As Eli Lilly gears up to support…
As Eli Lilly gears up to support its partnered athletes, [...]